The Epigenetic Clock Development Foundation (“Clock Foundation”) is a UCLA spin-out and non-profit that is speeding the availability of treatments that prolong health and life expectancy.  They are focused especially on the use of epigenetic ageing clocks and adaptive clinical trials. They will identify and develop key enabling technologies that are critical for this mission, identify promising teams that are able to use them, and make them available to our partners, including researchers, physicians/clinics, contract research organizations, and drug development companies.